Avalon GloboCare Corp. (AVCO) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
4400 ROUTE 9 FREEHOLD, NJ 07728 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 653 | 887 | 1,991 | 3,938 | 1,180 | 526 | |||
| Cash and cash equivalents | 653 | 887 | 1,991 | 3,938 | 1,180 | 526 | |||
| Receivables | 74 | 71 | 59 | 46 | |||||
| Prepaid expense | 46 | 67 | 250 | 101 | 15 | ||||
| Deferred costs | 225 | 35 | 139 | 139 | 139 | ||||
| Other current assets | 50 | 40 | 32 | ||||||
| Other undisclosed current assets | 448 | 362 | 309 | 19 | 174 | 187 | |||
| Total current assets: | 1,423 | 1,391 | 2,374 | 4,449 | 1,653 | 914 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 188 | 220 | 11 | 44 | 74 | 111 | |||
| Property, plant and equipment | 117 | 140 | 138 | 214 | 266 | 321 | |||
| Long-term investments and receivables | 485 | ||||||||
| Long-term investments | 485 | ||||||||
| Intangible assets, net (including goodwill) | 7,393 | 7,458 | 7,498 | ||||||
| Intangible assets, net (excluding goodwill) | 7,393 | 7,458 | 7,498 | ||||||
| Prepaid expense | 269 | 384 | |||||||
| Regulated entity, other noncurrent assets | 263 | ||||||||
| Restricted cash and investments | 139 | ||||||||
| Deferred costs | 97 | 102 | |||||||
| Other noncurrent assets | 212 | 378 | 384 | 322 | 75 | 75 | |||
| Other undisclosed noncurrent assets | 20,705 | 21,384 | 8,338 | 7,881 | 8,110 | 8,146 | |||
| Total noncurrent assets: | 29,148 | 29,581 | 17,378 | 8,461 | 8,622 | 8,755 | |||
| TOTAL ASSETS: | 30,571 | 30,972 | 19,752 | 12,911 | 10,275 | 9,669 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,430 | 2,875 | 2,347 | 2,525 | 3,524 | 3,587 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 380 | 375 | 480 | ||
| Accounts payable | 102 | 81 | 376 | ||||||
| Accrued liabilities | 2,430 | 2,773 | 2,347 | 2,064 | 2,773 | 3,107 | |||
| Debt | 1,000 | 750 | 493 | 660 | |||||
| Deferred compensation liability | 1,000 | 1,000 | |||||||
| Derivative instruments and hedges, liabilities | 97 | 2,013 | |||||||
| Due to related parties | ✕ | ✕ | ✕ | 100 | 100 | 540 | |||
| Other undisclosed current liabilities | 1,438 | 551 | 1,133 | 703 | 641 | 901 | |||
| Total current liabilities: | 5,965 | 5,176 | 3,580 | 3,328 | 7,210 | 5,148 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 6,387 | 5,335 | 4,563 | 4,556 | 2,440 | 2,850 | |||
| Long-term debt, excluding current maturities | 6,387 | 5,335 | 4,563 | 4,556 | 2,440 | 2,850 | |||
| Liabilities, other than long-term debt | 67 | 550 | 450 | 450 | 450 | 390 | |||
| Accounts payable and accrued liabilities | 450 | 450 | 450 | 450 | |||||
| Due to related parties | ✕ | ✕ | ✕ | 390 | |||||
| Operating lease, liability | 67 | 100 | |||||||
| Other undisclosed noncurrent liabilities | |||||||||
| Total noncurrent liabilities: | 6,454 | 5,885 | 5,013 | 5,006 | 2,890 | 3,240 | |||
| Total liabilities: | 12,419 | 11,062 | 8,593 | 8,334 | 10,101 | 8,388 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 18,151 | 19,910 | 11,159 | 4,577 | 174 | 1,281 | |||
| Preferred stock | 9,000 | 9,000 | |||||||
| Common stock | 1 | 1 | 1 | 10 | 9 | 9 | |||
| Treasury stock, value | (523) | (523) | (523) | (523) | (523) | (523) | |||
| Additional paid in capital | 67,277 | 66,481 | 65,950 | 65,372 | 56,119 | 55,153 | |||
| Accumulated other comprehensive loss | (220) | (209) | (213) | (244) | (207) | (163) | |||
| Accumulated deficit | (68,390) | (65,847) | (63,063) | (60,645) | (55,231) | (53,202) | |||
| Other undisclosed equity, attributable to parent | 20,007 | 11,007 | 7 | 607 | 7 | 7 | |||
| Total equity: | 18,151 | 19,910 | 11,159 | 4,577 | 174 | 1,281 | |||
| TOTAL LIABILITIES AND EQUITY: | 30,571 | 30,972 | 19,752 | 12,911 | 10,275 | 9,669 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 307 | 296 | 296 | 317 | 291 | 298 | ||
| Revenue from related parties | ✕ | ✕ | ✕ | 212 | 218 | |||
| Other income | (1) | (1) | (37) | 0 | 151 | 109 | ||
| Other undisclosed gross profit | (245) | (248) | (252) | (247) | (212) | (218) | ||
| Gross profit: | 62 | 48 | 44 | 70 | 79 | 79 | ||
| Operating expenses | (2,712) | (2,277) | (1,659) | (2,923) | (2,206) | |||
| Other operating income (expense), net | 62 | (2,712) | (344) | |||||
| Other expenses | (2,235) | (344) | ||||||
| Other undisclosed operating income (loss) | (1,988) | 2,712 | 344 | |||||
| Operating loss: | (1,865) | (2,664) | (2,233) | (1,589) | (2,844) | (2,127) | ||
| Nonoperating income (expense) | 308 | 34 | (559) | (485) | ||||
| Investment income, nonoperating | 308 | |||||||
| Other nonoperating income (expense) | (522) | (441) | ||||||
| Interest and debt expense | (177) | (2) | (42) | (55) | (32) | (40) | ||
| Loss from continuing operations before equity method investments, income taxes: | (1,733) | (2,666) | (2,242) | (2,203) | (3,360) | (2,167) | ||
| Income (loss) from equity method investments | (9) | 37 | (8) | (9) | (12) | |||
| Other undisclosed income (loss) from continuing operations before income taxes | (801) | (155) | (168) | (3,203) | 1,343 | 96 | ||
| Loss from continuing operations: | (2,543) | (2,784) | (2,418) | (5,414) | (2,028) | (2,071) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (5,414) | (2,028) | (2,071) | |
| Net loss: | (2,543) | (2,784) | (2,418) | (5,414) | (2,028) | (2,071) | ||
| Net loss attributable to noncontrolling interest | (2,071) | |||||||
| Other undisclosed net income attributable to parent | 2,071 | |||||||
| Net loss attributable to parent: | (2,543) | (2,784) | (2,418) | (5,414) | (2,028) | (2,071) | ||
| Preferred stock dividends and other adjustments | (11,000) | |||||||
| Other undisclosed net income available to common stockholders, basic | 13,793 | 2,426 | 5,423 | 2,040 | 2,083 | |||
| Net income (loss) available to common stockholders, diluted: | (2,543) | 9 | 8 | 9 | 12 | 13 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (2,543) | (2,784) | (2,418) | (5,414) | (2,028) | (2,071) | ||
| Other comprehensive income (loss) | 11 | (4) | 37 | 44 | (2) | |||
| Other undisclosed comprehensive income (loss) | (22) | 7 | 31 | (74) | (87) | 4 | ||
| Comprehensive loss: | (2,554) | (2,780) | (2,387) | (5,451) | (2,072) | (2,069) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (2,071) | |||||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 2,071 | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (2,554) | (2,780) | (2,387) | (5,451) | (2,072) | (2,069) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.